| Literature DB >> 30319525 |
Hendrikus J A van Os1, Lucas A Ramos2,3, Adam Hilbert2, Matthijs van Leeuwen4, Marianne A A van Walderveen5, Nyika D Kruyt1, Diederik W J Dippel6, Ewout W Steyerberg7,8, Irene C van der Schaaf9, Hester F Lingsma8, Wouter J Schonewille10, Charles B L M Majoie11, Silvia D Olabarriaga3, Koos H Zwinderman3, Esmee Venema6,8, Henk A Marquering2, Marieke J H Wermer1.
Abstract
Background: Endovascular treatment (EVT) is effective for stroke patients with a large vessel occlusion (LVO) of the anterior circulation. To further improve personalized stroke care, it is essential to accurately predict outcome after EVT. Machine learning might outperform classical prediction methods as it is capable of addressing complex interactions and non-linear relations between variables.Entities:
Keywords: endovascular treatment; functional outcome; ischemic stroke; machine learning; prediction; reperfusion
Year: 2018 PMID: 30319525 PMCID: PMC6167479 DOI: 10.3389/fneur.2018.00784
Source DB: PubMed Journal: Front Neurol ISSN: 1664-2295 Impact factor: 4.003
Figure 1Schematic representation of nested cross-validation methodology.
Baseline characteristics of participants.
| Mean age ± SD | 69.8 ± 14.4 |
| Men, | 738 (53.5) |
| NIHSS score, | 16 (11–20) |
| Mean systolic blood pressure ± SD | 150 ± 25 |
| Atrial fibrillation | 411 (30.7) |
| Hypertension | 697 (51.1) |
| Diabetes mellitus | 235 (17.1) |
| Myocardial infarction | 216 (15.9) |
| Peripheral artery disease | 127 (9.4) |
| Ischaemic stroke | 227 (16.5) |
| Hypercholesterolemia | 411 (29.7) |
| Pre-stroke mRS > 2, | 158 (11.6) |
| Smoking, | 314 (22.9) |
| DOAC | 35 (2.6) |
| Coumarine | 179 (13.0) |
| Antiplatelet | 461 (33.7) |
| Heparin | 52 (3.8) |
| Blood pressure medication | 707 (52.1) |
| Statin | 490 (36.2) |
| Intravenous alteplase treatment, | 1,054 (76.2) |
| ASPECTS, | 9 (7–10) |
| Time from stroke onset to groin in minutes, | 210 (160–270) |
| Collateral score ≥ 2 | 764 (55) |
National Institutes of Health Stroke Scale score.
Direct oral anticoagulant drugs.
Discrimination of machine learning algorithms and logistic regression models across the various prediction settings.
| Super learner | 0.55 (0.54–0.56) | 0.79 (0.79–0.80) | 0.90 (0.90–0.91) |
| Random forests | 0.55 (0.55–0.56) | 0.79 (0.79–0.79) | 0.91 (0.90–0.91) |
| Support vector machine | 0.53 (0.53–0.54) | 0.78 (0.77–0.78) | 0.88 (0.88–0.89) |
| Neural network | 0.53 (0.53–0.54) | 0.77 (0.76–0.77) | 0.88 (0.88–0.89) |
| Random forests | 0.55 (0.55–0.56) | 0.78 (0.78–0.78) | 0.90 (0.90–0.90) |
| LASSO | NA | 0.78 (0.78–0.79) | 0.90 (0.89–0.90) |
| Elastic net | NA | 0.77 (0.77–0.78) | 0.89 (0.88–0.89) |
| Backward elimination | 0.57 (0.57–0.58) | 0.78 (0.77–0.78) | 0.90 (0.89–0.90) |
| LR: prior knowledge | 0.55 (0.55–0.58) | 0.78 (0.78–0.79) | 0.90 (0.90–0.90) |
Model discrimination is assessed by calculating mean Area Under the Curve (AUC) of the receiver operating characteristic across all outer cross-validation folds.
Logistic regression using automated variable selection methods.
Variable selection not possible, likely due to insufficient signal-to-noise ratio.
Logistic regression using variables based on prior knowledge.
Variable importance of Random Forests for various prediction settings (used variables: predicted outcome).
| RR systolic at admission | 100 | Age | 100 | NIHSS after 24–48 h | 100 |
| Duration stroke onset to groin | 100 | NIHSS at baseline | 100 | Delta NIHSS: follow-up minus baseline | 100 |
| RR diastolic at admission | 100 | Duration stroke onset to groin | 100 | Age | 100 |
| Thrombocyte count | 100 | Glasgow Coma Scale | 100 | NIHSS at baseline | 100 |
| Age | 100 | RR systolic at admission | 100 | Duration from onset to recanalization | 100 |
| Creatinine | 100 | CRP | 100 | Duration of procedure | 100 |
| CRP | 100 | Creatinine | 100 | Delta NIHSS ≥ 4 points higher after EVT | 100 |
| NIHSS at baseline | 100 | Thrombocyte count | 100 | Duration stroke onset to groin | 100 |
| Clot burden score | 100 | RR diastolic at admission | 100 | Glasgow Coma Scale | 100 |
| Glasgow ComaScale | 100 | mRS prior to stroke | 100 | Creatinine | 100 |
| ASPECTS score at baseline | 100 | ASPECTS score at baseline | 100 | CRP | 100 |
| Glucose | 100 | Glucose | 100 | Thrombocyte count | 100 |
| Location: proximal M1 | 74 | Clot burden score | 99 | RR systolic at admission | 100 |
| Hyperdense artery sign on NCCT | 50 | Presence of leukoaraiosis | 96 | mRS prior to stroke | 91 |
| History of atrial fibrillation | 32 | Collateral score | 77 | RR diastolic at admission | 93 |
NCCT, non-contrast CT; CRP, C-Reactive Protein; RR, blood pressure; NIHSS, National Institutes of Health Stroke Scale score.
Frequency of being among the 15 most important variables in a Random Forests model for each of the 100 external CV folds.
Location of intracranial occlusion on CTA.